Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcello Marrone, Luiz Carlos, Marrone, Bianca Fontana, Pascoal, Tharick Ali, Schilling, Lucas Porcello, Soder, Ricardo Bernardi, Ferreira, Sheila Schuch, Gadonski, Giovani, da Costa, Jaderson Costa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600224/
https://www.ncbi.nlm.nih.gov/pubmed/23533871
http://dx.doi.org/10.1155/2013/306983
_version_ 1782475609070370816
author Porcello Marrone, Luiz Carlos
Marrone, Bianca Fontana
Pascoal, Tharick Ali
Schilling, Lucas Porcello
Soder, Ricardo Bernardi
Ferreira, Sheila Schuch
Gadonski, Giovani
da Costa, Jaderson Costa
author_facet Porcello Marrone, Luiz Carlos
Marrone, Bianca Fontana
Pascoal, Tharick Ali
Schilling, Lucas Porcello
Soder, Ricardo Bernardi
Ferreira, Sheila Schuch
Gadonski, Giovani
da Costa, Jaderson Costa
author_sort Porcello Marrone, Luiz Carlos
collection PubMed
description Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
format Online
Article
Text
id pubmed-3600224
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36002242013-03-26 Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy Porcello Marrone, Luiz Carlos Marrone, Bianca Fontana Pascoal, Tharick Ali Schilling, Lucas Porcello Soder, Ricardo Bernardi Ferreira, Sheila Schuch Gadonski, Giovani da Costa, Jaderson Costa Case Rep Oncol Med Case Report Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer. Hindawi Publishing Corporation 2013 2013-02-27 /pmc/articles/PMC3600224/ /pubmed/23533871 http://dx.doi.org/10.1155/2013/306983 Text en Copyright © 2013 Luiz Carlos Porcello Marrone et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Porcello Marrone, Luiz Carlos
Marrone, Bianca Fontana
Pascoal, Tharick Ali
Schilling, Lucas Porcello
Soder, Ricardo Bernardi
Ferreira, Sheila Schuch
Gadonski, Giovani
da Costa, Jaderson Costa
Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_full Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_fullStr Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_full_unstemmed Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_short Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
title_sort posterior reversible encephalopathy syndrome associated with folfox chemotherapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600224/
https://www.ncbi.nlm.nih.gov/pubmed/23533871
http://dx.doi.org/10.1155/2013/306983
work_keys_str_mv AT porcellomarroneluizcarlos posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT marronebiancafontana posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT pascoaltharickali posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT schillinglucasporcello posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT soderricardobernardi posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT ferreirasheilaschuch posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT gadonskigiovani posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy
AT dacostajadersoncosta posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy

Ejemplares similares